Zobrazeno 1 - 10 of 86 pro vyhledávání: '"Loes M Hollestein"'
1
Akademický článek
Efficacy, cost-minimization, and budget impact of a personalized discharge letter for basal cell carcinoma patients to reduce low-value follow-up care.
Autor: Sven van Egmond, Ella D van Vliet, Marlies Wakkee, Loes M Hollestein, Xavier G L V Pouwels, Hendrik Koffijberg, Yesim Misirli, Rachel S L A Bakkum, Maarten T Bastiaens, Nicole A Kukutsch, Albert J Oosting, Elsemieke I Plasmeijer, Annik van Rengen, Kees-Peter de Roos, Tamar E C Nijsten, Esther de Vries, Esther W de Bekker-Grob
Publikováno v: PLoS ONE, Vol 17, Iss 1, p e0260978 (2022)
BackgroundThe incidence of keratinocyte carcinomas is high and rapidly growing. Approximately 80% of keratinocyte carcinomas consist of basal cell carcinomas (BCC) with 50% of these being considered as low-risk tumors. Nevertheless, 83% of the low-ri
Externí odkaz: https://doaj.org/article/fefbeba1887544388395c6c9f6c6af0c
Zobrazit plný text záznamu
2
Akademický článek
Weighted metrics are required when evaluating the performance of prediction models in nested case–control studies
Autor: Barbara Rentroia-Pacheco, Domenico Bellomo, Inge M. M. Lakeman, Marlies Wakkee, Loes M. Hollestein, David van Klaveren
Publikováno v: BMC Medical Research Methodology, Vol 24, Iss 1, Pp 1-17 (2024)
Abstract Background Nested case–control (NCC) designs are efficient for developing and validating prediction models that use expensive or difficult-to-obtain predictors, especially when the outcome is rare. Previous research has focused on how to d
Externí odkaz: https://doaj.org/article/15095719da6b4ddaae30480a1597cc54
Zobrazit plný text záznamu
3
Akademický článek
Personalised decision making to predict absolute metastatic risk in cutaneous squamous cell carcinoma: development and validation of a clinico-pathological modelResearch in context
Autor: Barbara Rentroia-Pacheco, Selin Tokez, Edo M. Bramer, Zoe C. Venables, Harmen J.G. van de Werken, Domenico Bellomo, David van Klaveren, Antien L. Mooyaart, Loes M. Hollestein, Marlies Wakkee
Publikováno v: EClinicalMedicine, Vol 63, Iss , Pp 102150- (2023)
Summary: Background: Cutaneous squamous cell carcinoma (cSCC) is a common skin cancer, affecting more than 2 million people worldwide yearly and metastasising in 2–5% of patients. However, current clinical staging systems do not provide estimates o
Externí odkaz: https://doaj.org/article/5c3c9ba20bcf412bb28d2d5305289726
Zobrazit plný text záznamu
6
Limited impact of COVID ‐19‐related diagnostic delay on cutaneous melanoma and squamous cell carcinoma tumour characteristics: a nationwide pathology registry analysis
Autor: Tobias E. Sangers, Marlies Wakkee, Eline C. Kramer‐Noels, Tamar Nijsten, Marieke W.J. Louwman, Elisabeth H. Jaspars, Loes M. Hollestein
Publikováno v: British Journal of Dermatology, 187(2), 196-202. Wiley-Blackwell
British Journal of Dermatology, 187(2), 196-202. Wiley-Blackwell Publishing Ltd
Sangers, T E, Wakkee, M, Kramer-Noels, E C, Nijsten, T, Louwman, M W J, Jaspars, E H & Hollestein, L M 2022, ' Limited impact of COVID-19-related diagnostic delay on cutaneous melanoma and squamous cell carcinoma tumour characteristics : a nationwide pathology registry analysis ', British Journal of Dermatology, vol. 187, no. 2, pp. 196-202 . https://doi.org/10.1111/bjd.21050
Background: The COVID-19 pandemic reduced the number of skin cancer diagnoses, potentially causing a progression to unfavourable tumour stages. Objectives: To identify the impact of delayed diagnostics on primary invasive melanoma and cutaneous squam
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fbbdbbf91eb3b26b10675e3fad51b3c6
https://doi.org/10.1111/bjd.21050
Zobrazit plný text záznamu
7
A nationwide study of the incidence and trends of first and multiple basal cell carcinomas in the Netherlands and prediction of future incidence*
Autor: Tamar Nijsten, Marlies Wakkee, K Schreuder, Loes M. Hollestein, Marieke W. J. Louwman
Publikováno v: British Journal of Dermatology, 186(3), 476-484. Wiley-Blackwell Publishing Ltd
Background: Basal cell carcinoma (BCC) is the most frequently diagnosed malignancy worldwide and an ever increasing annual incidence is observed. However, nationwide registries of BCCs are very rare, and often extrapolation of the data has been neces
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1422e16d9adaf353617309c7f860be26
https://pure.eur.nl/en/publications/b3784a1c-d142-402b-9a97-4dfd4a07daba
Zobrazit plný text záznamu
8
Cumulative incidence and disease-specific survival of metastatic cutaneous squamous cell carcinoma
Autor: Marieke W. J. Louwman, Selin Tokez, Loes M. Hollestein, Marlies Wakkee, Wilner Christopher Kan, Antien L. Mooyaart, Z. C. Venables, Tamar Nijsten
Publikováno v: Journal of the American Academy of Dermatology, 86(2), 331-338. Mosby Inc.
Background Cutaneous squamous cell carcinoma (cSCC) represents the most serious form of keratinocyte cancers because of its metastatic potential. Studies on nationwide incidence and disease-specific survival rates of metastatic cSCC (mcSCC) are lacki
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::04bead6ab10e88e6134d9ad6b3cd34be
https://doi.org/10.1016/j.jaad.2021.09.067
Zobrazit plný text záznamu
9
A 5-year retrospective review of skin adnexal tumours received at a tertiary dermatopathology service: implications for linked genetic diagnoses
Autor: Loes M. Hollestein, S Cook, Neil Rajan, D Bajwa, A. Husain
Publikováno v: British Journal of Dermatology. 186:167-173
Summary Background Skin adnexal tumours (SATs) comprise a diverse range of neoplasms, which are difficult to diagnose clinically. They present in paediatric and adult populations, and may be indicative of an underlying genetic syndrome. There is a la
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::79989f0a910c6644bb979b46c34b327e
https://doi.org/10.1111/bjd.20701
Zobrazit plný text záznamu
10
Practice Variation in Skin Cancer Treatment and Follow-Up Care
Autor: Carin A. Uyl-de Groot, Sven van Egmond, Loes M. Hollestein, Judith A van Erkelens, Tamar Nijsten, Marlies Wakkee
Publikováno v: Dermatology, 237(6), 1000-1006. Karger
Background: Quality indicators are used to benchmark and subsequently improve quality of healthcare. However, defining good quality indicators and applying them to high-volume care such as skin cancer is not always feasible. Objectives: To determine
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::12c572e294ee8f6372b64db58afa176f
https://pure.eur.nl/en/publications/32e4bb35-d64e-488c-acca-ad814fcd35e3
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje